Cited by 58Neuroscience and Neural EngineeringTactile and Sensory InteractionsPain Management and Treatment

Contemporary approaches to visual prostheses

Open access
Mirochnik, Rebecca M., Pezaris, John S.·2019·Military Medical Research

Abstract

Visual prostheses serve to restore visual function following acquired blindness. Acquired blindness (as opposed to congenital blindness) has many causes, including diseases such as retinitis pigmentosa, glaucoma, and macular degeneration, or trauma such as caused by automobile accident or blast damage from explosions. Many of the blindness-causing diseases target the retina or other ocular structure. Often, despite the loss of sensitivity to light, the remainder of the visual pathway is still functional, enabling electrical devices to deliver effective and meaningful visual information to the brain via arrays of electrodes. These arrays can be placed in any part of the early visual pathway, such as the retina, optic nerve, lateral geniculate nucleus, or visual cortex. A camera or other imaging source is used to drive electrical stimulation of remaining healthy cells or structures to create artificial vision and provide restoration of function. In this review, each approach to visual prostheses is described, including advantages and disadvantages as well as assessments of the current state of the art. Most of the work to-date has been targeting stimulation of (a) the retina, with three devices approved for general use and two more in clinical testing; (b) the lateral geniculate nucleus, with efforts still in the pre-clinical stage; and (c) the cortex, with three devices in clinical testing and none currently approved for general use despite the longest history of investigation of the three major approaches. Each class of device has different medical indications, and different levels of invasiveness required for implantation. All contemporary devices deliver relatively poor vision. There has been remarkable progress since the first proof-of-concept demonstration that used stimulation of the primary visual cortex, with the field exploring all viable options for restoration of function. Much of the progress has been recent, driven by advances in microelectronics and biocompatibility. With three devices currently approved for general use in various parts of the world, and a handful of additional devices well along in the pipeline toward approval, prospects for wide deployment of a device-based therapy to treat acquired blindness are good.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40779-019-0206-9

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Prospective approaches such as gene and cell therapies or optogenetics only focus on the retina and are ineffective when pathologies irremediably damage the retina or the optic nerve.

    “Prospective approaches, like gene and cell therapies or optogenetics, only focus on the retina [5,6], and they are ineffective when pathologies irremediably damage the retina or the optic nerve [7,8].”
  • The LGN is a stratified compact structure in the thalamus receiving input from the optic nerve and relaying information to the primary visual cortex.

    “The LGN is a stratified compact structure in the thalamus receiving input from the optic nerve and relaying information to the primary visual cortex [7].”
  • A cortical prosthesis offers the advantage of artificial vision in most conditions of blindness, excluding traumatic brain injuries and stroke.

    “A cortical prosthesis offers the advantage of artificial vision in most conditions of blindness, excluding traumatic brain injuries and stroke [7].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 80 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Mirochnik, R. M., & Pezaris, J. S.
Affiliations
  • Northeastern University (US)
  • Harvard University (US)
Corresponding author
Pezaris, John S.
Venue
Military Medical Research
Publisher
Elsevier BV
Published
2019-06-05
Volume
6
Issue
1
Pages
19-19
ISSN
2054-9369 (ISSN-L)
OpenAlex
W2948931117
Cited by
58
References
80
Citations by year
2026: 5 · 2025: 4 · 2024: 8 · 2023: 11 · 2022: 10 · 2021: 12 · 2020: 8
FWCI
1.00
Type
journal article
Language
en
Open access
Locations
  • Military Medical Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
William M. Wood Foundation (Visual Prosthesis Laboratory)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neural Engineering
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Tactile and Sensory Interactions
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
Keywords
retinal prosthesis, acquired blindness, visual cortex stimulation, electrode arrays, retinitis pigmentosa, glaucoma, macular degeneration, visual pathway, artificial vision, biocompatibility, biomedical implants
MeSH terms
Blindness, Clinical Trials as Topic, Electric Stimulation Therapy, Humans, Optic Nerve, Visual Cortex, Visual Prosthesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review